- Home
- NAMS vs SAH Comparison
NAMS vs SAH Comparison
Compare NAMS & SAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAMS
- SAH
- Stock Information
- Founded
- NAMS 2019
- SAH 1997
- Country
- NAMS Netherlands
- SAH United States
- Employees
- NAMS N/A
- SAH N/A
- Industry
- NAMS Biotechnology: Pharmaceutical Preparations
- SAH Other Specialty Stores
- Sector
- NAMS Health Care
- SAH Consumer Discretionary
- Exchange
- NAMS Nasdaq
- SAH Nasdaq
- Market Cap
- NAMS 3.1B
- SAH 2.8B
- IPO Year
- NAMS N/A
- SAH 1997
- Fundamental
- Price
- NAMS $36.14
- SAH $64.86
- Analyst Decision
- NAMS Strong Buy
- SAH Buy
- Analyst Count
- NAMS 10
- SAH 8
- Target Price
- NAMS $43.70
- SAH $81.88
- AVG Volume (30 Days)
- NAMS 1.4M
- SAH 181.3K
- Earning Date
- NAMS 11-06-2025
- SAH 10-23-2025
- Dividend Yield
- NAMS N/A
- SAH 2.36%
- EPS Growth
- NAMS N/A
- SAH N/A
- EPS
- NAMS N/A
- SAH 3.73
- Revenue
- NAMS $64,006,000.00
- SAH $15,178,100,000.00
- Revenue This Year
- NAMS N/A
- SAH $4.86
- Revenue Next Year
- NAMS $1.67
- SAH $3.51
- P/E Ratio
- NAMS N/A
- SAH $17.37
- Revenue Growth
- NAMS 762.15
- SAH 9.09
- 52 Week Low
- NAMS $14.06
- SAH $52.00
- 52 Week High
- NAMS $41.47
- SAH $89.62
- Technical
- Relative Strength Index (RSI)
- NAMS 60.09
- SAH 29.00
- Support Level
- NAMS $34.34
- SAH $70.70
- Resistance Level
- NAMS $37.21
- SAH $77.85
- Average True Range (ATR)
- NAMS 2.47
- SAH 2.77
- MACD
- NAMS -0.34
- SAH -0.89
- Stochastic Oscillator
- NAMS 46.32
- SAH 11.87
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About SAH Sonic Automotive Inc.
Sonic Automotive is one of the largest auto dealership groups in the United States. The company has 108 franchised stores in 18 states, primarily in metropolitan areas in California, Texas, and the Southeast, plus 18 EchoPark used-vehicle stores, 16 collision centers, and 14 powersports locations. The franchise stores derive revenue from new and used vehicles plus parts and collision repair, finance, insurance, and wholesale auctions. Luxury and import dealerships make up about 86% of franchise new-vehicle revenue, while Honda, BMW, Mercedes, and Toyota constitute about 59% of new-vehicle revenue. BMW is the largest brand at about 25%. 2024's revenue was $14.2 billion, with Texas and California comprising 51% of the total. EchoPark's portion was $2.1 billion.